Clinical Trial Update: Zostavax in Systemic Lupus Erythematosus [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating Zostavax in patients with systemic lupus erythematosus has completed. The study, sponsored by the Oklahoma Medical Research Foundation,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Zostavax (Varicella zoster vaccine live)

Snippet

Sponsor: Oklahoma Medical Research Foundation | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: COMPLETED